National committee statement as a missed opportunity to acknowledge the relevance of a biopsychosocial approach in understanding long COVID
- PMID: 38272788
- DOI: 10.1016/j.jpsychores.2024.111596
National committee statement as a missed opportunity to acknowledge the relevance of a biopsychosocial approach in understanding long COVID
Conflict of interest statement
Declaration of competing interest Dr. Lemogne reports non-financial support from Nordic Pharma France, outside the submitted work, and research grants from the ANRS|MIE, the Assistance Publique – Hôpitaux de Paris (AP-HP), and the Fondation de l'AP-HP. Dr. Scherlinger is a consultant for Amgen, AstraZeneca, Biogen, BMS, Galapagos, Nordic Pharma, Novartis, Sandoz on topics unrelated to this work; and received research grants from Inserm, Bettencourt-Schueller foundation, ATIP-Avenir, Arthritis Foundation and the Foundation for Research in Rheumatology (Foreum). Dr. Pitron reports speaking fees from Grünenthal, outside the submitted work. Dr. Ranque reports a research grant from the ANRS|MIE.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical